Opsumit 10MG-QTY 2 @ 6,270.03 NOV FY26- emergency order 12,540.06
Ended Awarded Last action
- Contract number
- 15B50526F00000024
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $12,540
Award facts
- Contract value 100% obligated
- $12,540.06 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Titusville, Hopewell Township, NJ 08560, USA
Award details come from SAM.gov/FPDS.
About this award
Actelion Pharmaceuticals US, Inc. has been awarded a firm fixed-price delivery order valued at $12.5M by the Federal Medical Center Carswell for an emergency procurement of Opsumit 10mg (quantity 2 at $6,270.03 each), with an ultimate completion date of December 3, 2025. This delivery order was issued without a small business set-aside designation and represents direct pharmaceutical procurement under the company's existing Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs. The award was made by a civilian federal agency to support critical medication supply needs within the federal healthcare system.
Actelion Pharmaceuticals US, Inc., headquartered in Titusville, New Jersey, specializes in the development and distribution of medications for rare diseases, particularly pulmonary arterial hypertension treatments. The company maintains three significant Indefinite Delivery Vehicles through the National Acquisition Center and Department of Veterans Affairs, including a multiple-award Federal Supply Schedule contract valued at $219.1B through July 2029, enabling efficient procurement of specialized pharmaceutical products by federal medical centers and correctional facilities. This delivery order exemplifies Actelion's established role as a critical supplier of specialized drug therapies to federal healthcare institutions serving veterans, inmates, and other eligible beneficiaries.
Quick answers
Who was awarded contract 15B50526F00000024?
15B50526F00000024 was awarded to Actelion Pharmaceuticals US, Inc. by Federal Medical Center Carswell (Correctional Facilities) on December 3, 2025.
How much is contract 15B50526F00000024 worth?
The government has obligated $12,540 on 15B50526F00000024.
Is contract 15B50526F00000024 an order under another contract?
Yes. 15B50526F00000024 is a delivery order under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000024 competed?
The extent of competition for 15B50526F00000024 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award